Cargando…
Prospects for Foamy Viral Vector Anti-HIV Gene Therapy
Stem cell gene therapy approaches for Human Immunodeficiency Virus (HIV) infection have been explored in clinical trials and several anti-HIV genes delivered by retroviral vectors were shown to block HIV replication. However, gammaretroviral and lentiviral based retroviral vectors have limitations f...
Autores principales: | Nalla, Arun K., Trobridge, Grant D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344253/ https://www.ncbi.nlm.nih.gov/pubmed/28536375 http://dx.doi.org/10.3390/biomedicines4020008 |
Ejemplares similares
-
Foamy Virus Vectors for HIV Gene Therapy
por: Olszko, Miles E., et al.
Publicado: (2013) -
Large Animal Models for Foamy Virus Vector Gene Therapy
por: Trobridge, Grant D., et al.
Publicado: (2012) -
Evidence for the in vivo safety of insulated foamy viral vectors
por: Browning, Diana L., et al.
Publicado: (2016) -
A comparison of foamy and lentiviral vector genotoxicity in SCID-repopulating cells shows foamy vectors are less prone to clonal dominance
por: Everson, Elizabeth M, et al.
Publicado: (2016) -
Foamy Virus Integrase in Development of Viral Vector for Gene Therapy
por: Kim, Jinsun, et al.
Publicado: (2020)